trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Adenomyosis D062788 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Visceral Pain D059265 1 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Capsule Opacification D058442 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Inoue H et al. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis. 2002 Int. J. Mol. Med. pmid:11956660
Stimson KM and Vertino PM Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. 2002 J. Biol. Chem. pmid:11733524
Sawa H et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. 2002 Brain Tumor Pathol pmid:12622137
Suzuki-Mizushima Y et al. Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells. 2002 Brain Res. pmid:12270499
Boutillier AL et al. Constitutive repression of E2F1 transcriptional activity through HDAC proteins is essential for neuronal survival. 2002 Ann. N. Y. Acad. Sci. pmid:12485907
Zarnegar R et al. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor. 2002 Surgery pmid:12490845
Chen T et al. Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. 2002 Arch. Biochem. Biophys. pmid:12464268
Rombouts K et al. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. 2002 J. Hepatol. pmid:12445420
Guo WH et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. 2002 Oncogene pmid:12447699
Marin-Husstege M et al. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. 2002 J. Neurosci. pmid:12451133
Wang ZM et al. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. 2002 Ai Zheng pmid:12508652
Duharcourt S and Yao MC Role of histone deacetylation in developmentally programmed DNA rearrangements in Tetrahymena thermophila. 2002 Eukaryotic Cell pmid:12455963
Strait KA et al. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. 2002 Mol. Cancer Ther. pmid:12479699
Lim Y et al. Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts. 2002 J. Biol. Chem. pmid:11821402
Wilson MA et al. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. 2002 J. Biol. Chem. pmid:11821430
Deroanne CF et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. 2002 Oncogene pmid:11821955
Ego T et al. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. 2002 Oncogene pmid:12370815
Zhang W and Kone BC NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. 2002 Am. J. Physiol. Renal Physiol. pmid:12372765
Handumrongkul C et al. Distinct sets of cellular genes control the expression of transfected, nuclear-localized genes. 2002 Mol. Ther. pmid:11829526
Ailenberg M and Silverman M Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression. 2002 Biochem. Biophys. Res. Commun. pmid:12379227
Herold C et al. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. 2002 J. Hepatol. pmid:11830335
Yamashita K et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. 2002 Cancer Cell pmid:12498717
Zhou DC et al. Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. 2002 Blood pmid:11830487
Fahrner JA et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. 2002 Cancer Res. pmid:12499261
Valapour M et al. Histone deacetylation inhibits IL4 gene expression in T cells. 2002 J. Allergy Clin. Immunol. pmid:11842291
McBurney MW et al. Evidence for repeat-induced gene silencing in cultured Mammalian cells: inactivation of tandem repeats of transfected genes. 2002 Exp. Cell Res. pmid:11855851
Hou M et al. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. 2002 Exp. Cell Res. pmid:11855854
Remiszewski SW et al. Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. 2002 J. Med. Chem. pmid:11831887
Kiefer SM et al. Murine Sall1 represses transcription by recruiting a histone deacetylase complex. 2002 J. Biol. Chem. pmid:11836251
Roddie PH et al. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1. 2002 Leukemia pmid:11840267
Taniura S et al. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. 2002 J. Biol. Chem. pmid:11877441
Heltweg B and Jung M A microplate reader-based nonisotopic histone deacetylase activity assay. 2002 Anal. Biochem. pmid:11878795
Kamitani H et al. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. 2002 Neuro-oncology pmid:11916500
Kishikawa S et al. Roles of histone acetylation in the Dnmt1 gene expression. 2002 Nucleic Acids Res. Suppl. pmid:12903179
Ginjala V et al. Multiple cis elements within the Igf2/H19 insulator domain organize a distance-dependent silencer. A cautionary note. 2002 J. Biol. Chem. pmid:11777900
Cabral AL et al. Regulation of the cellular prion protein gene expression depends on chromatin conformation. 2002 J. Biol. Chem. pmid:11739375
Park SH et al. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. 2002 J. Biol. Chem. pmid:11744689
Suenaga M et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. 2002 Int. J. Cancer pmid:11807787
Kikuchi T et al. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. 2002 Int. J. Cancer pmid:11774276
Rombouts K et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. 2002 Exp. Cell Res. pmid:12169274
Waterborg JH and Kapros T Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa. 2002 Biochem. Cell Biol. pmid:12123281
Mikkelsen IM et al. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif. 2002 Biochem. Pharmacol. pmid:12123752
Petti MC et al. Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies. 2002 Blood pmid:12130525
Avram D et al. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. 2002 Biochem. J. pmid:12196208
Guo Y et al. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. 2002 J. Biol. Chem. pmid:12198113
Wittich S et al. Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. 2002 J. Med. Chem. pmid:12109913
Toyooka S et al. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. 2002 Clin. Cancer Res. pmid:12114433
Choi HS et al. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. 2002 Biochem. Biophys. Res. Commun. pmid:12200149
Maecker HL et al. Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. 2002 Cancer Cell pmid:12204534
Fang D et al. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. 2002 Nucleic Acids Res. pmid:12136092
Zschocke J et al. Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells. 2002 J. Biol. Chem. pmid:12138116
Yu Z et al. Histone deacetylases augment cytokine induction of the iNOS gene. 2002 J. Am. Soc. Nephrol. pmid:12138131
Li J et al. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. 2002 Mol. Cell. Biol. pmid:12138181
Aapola U et al. Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. 2002 Nucleic Acids Res. pmid:12177302
Chang TH and Szabo E Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. 2002 Clin. Cancer Res. pmid:11948134
Ventura A et al. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. 2002 J. Biol. Chem. pmid:11948181
Gradoville L et al. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. 2002 J. Virol. pmid:11991990
Uesato S et al. Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group. 2002 Bioorg. Med. Chem. Lett. pmid:11992774
Nambiar MP et al. Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling. 2002 J. Cell. Biochem. pmid:11967985
Fu M et al. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. 2002 Mol. Cell. Biol. pmid:11971970
Koyama N et al. Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. 2002 Biochem. Biophys. Res. Commun. pmid:11944905
Nair RR et al. Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes. 2002 Mol. Ther. pmid:11945073
Qiu P and Li L Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. 2002 Circ. Res. pmid:11988486
Mai A et al. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. 2002 J. Med. Chem. pmid:11960489
Merezak C et al. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. 2002 J. Virol. pmid:11967319
Weston AD et al. Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. 2002 J. Cell Biol. pmid:12105181
Toyooka S et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. 2002 Oncogene pmid:12082623
Maehara K et al. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. 2002 Biochem. Biophys. Res. Commun. pmid:12083788
Iezzi S et al. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12032356
Nielsen J Combinatorial synthesis of natural products. 2002 Curr Opin Chem Biol pmid:12023109
Mikkelsen IM et al. The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. 2002 Mol. Cell. Biochem. pmid:12030384
Bharadwaj S and Prasad GL Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. 2002 Cancer Lett. pmid:12065096
Ito K et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12070353
Katula KS et al. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A. 2002 Arch. Biochem. Biophys. pmid:12054478
Wang XQ et al. Histone deacetylase inhibition results in decreased macrophage CD9 expression. 2002 Biochem. Biophys. Res. Commun. pmid:12056820
Rahmani M et al. The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated process. 2002 Exp. Cell Res. pmid:12061815
Woo SH et al. Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors. 2002 J. Med. Chem. pmid:12061890
Chen Y et al. On the epigenetic regulation of the human reelin promoter. 2002 Nucleic Acids Res. pmid:12087179
Zhang Y and Dufau ML Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. 2002 J. Biol. Chem. pmid:12091390
Danbara M et al. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. 2002 Mol. Immunol. pmid:12044782
Lin HM et al. Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors. 2002 J. Biol. Chem. pmid:12048199
Scott GK et al. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. 2002 Mol. Cancer Ther. pmid:12477051
Quivy V et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. 2002 J. Virol. pmid:12368351
Smith WL and Edlind TD Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. 2002 Antimicrob. Agents Chemother. pmid:12384361
Im H et al. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain. 2002 Biochemistry pmid:12484752
Gong XQ and Li L Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. 2002 J. Biol. Chem. pmid:11809751
Rössig L et al. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. 2002 Circ. Res. pmid:12411399
Gálfi P et al. Apoptosis sensitivity is not correlated with sensitivity to proliferation inhibition by the histone deacetylase inhibitors butyrate and TSA. 2002 Cancer Lett. pmid:12406559
Travers H et al. Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A. 2002 Exp. Cell Res. pmid:12413881
Wilson AJ et al. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. 2002 Cancer Res. pmid:12414619
Choy JS and Kron SJ NuA4 subunit Yng2 function in intra-S-phase DNA damage response. 2002 Mol. Cell. Biol. pmid:12417725
Ghoshal K et al. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. 2002 Mol. Cell. Biol. pmid:12417732
Hauser C et al. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. 2002 Mol. Cell. Biol. pmid:12391151
Westendorf JJ et al. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. 2002 Mol. Cell. Biol. pmid:12391164
Hoshimoto A et al. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. 2002 Br. J. Pharmacol. pmid:12010777
McGuinness MC et al. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. 2001 Sep-Oct Mol. Genet. Metab. pmid:11592822
Rombouts K et al. Trichostatin A, lead compound for development of antifibrogenic drugs. 2001 Jul-Sep Acta Gastroenterol. Belg. pmid:11680040
Jorgensen JS and Nilson JH AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. 2001 Mol. Endocrinol. pmid:11518798
Wang H et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. 2001 Science pmid:11387442
Feng YQ et al. Position effects are influenced by the orientation of a transgene with respect to flanking chromatin. 2001 Mol. Cell. Biol. pmid:11113204